Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Phase 3, 12-week, Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Efficacy, Safety, and Tolerability of 2 Fixed Doses of Brexpiprazole in the Treatment of Alzheimer's Agitation

ClinicalTrials.gov ID: NCT01862640

Public ClinicalTrials.gov record NCT01862640. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 27, 2026, 12:05 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, 12-week, Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Efficacy, Safety, and Tolerability of 2 Fixed Doses of Brexpiprazole (OPC-34712) in the Treatment of Subjects With Agitation Associated With Dementia of the Alzheimer's Type

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

To compare the efficacy of 2 fixed doses of brexpiprazole with placebo in participants with agitation associated with dementia of the Alzheimer's type.

Study identification

NCT ID
NCT01862640
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Enrollment
433 participants

Conditions and interventions

Eligibility (public fields only)

Age range
55 Years to 90 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 11, 2013 (Actual)
Primary completion
Mar 15, 2017 (Actual)
Completion
Mar 15, 2017 (Actual)
Last update posted
Dec 31, 2020

2013 – 2017

United States locations

U.S. sites
37
U.S. states
15
U.S. cities
28
Facility City State ZIP Site status
Not listed Tuscaloosa Alabama 35404 —
Not listed Phoenix Arizona 85013 —
Not listed Bellflower California 90706 —
Not listed Costa Mesa California 92627 —
Not listed Downey California 90706 —
Not listed Orange California 92868 —
Not listed Redlands California 92373 —
Not listed Yorba Linda California 92886 —
Not listed Norwalk Connecticut 06851 —
Not listed Coconut Creek Florida 33024 —
Not listed Hialeah Florida 33012 —
Not listed Hialeah Florida 33013 —
Not listed Hialeah Florida 33018 —
Not listed Lauderhill Florida 33319 —
Not listed Miami Florida 33122 —
Not listed Miami Florida 33126 —
Not listed Miami Florida 33136 —
Not listed Miami Florida 33137 —
Not listed Miami Florida 33145 —
Not listed Miami Florida 33161 —
Not listed Miami Florida 33174 —
Not listed Miami Springs Florida 33166 —
Not listed Sarasota Florida 34239 —
Not listed Decatur Georgia 30033 —
Not listed Suwanee Georgia 30024 —
Not listed Weymouth Massachusetts 02190 —
Not listed St Louis Missouri 63128 —
Not listed St Louis Missouri 63141 —
Not listed Las Vegas Nevada 89148 —
Not listed Mount Arlington New Jersey 07856 —
Not listed Paterson New Jersey 08759 —
Not listed Toms River New Jersey 08755 —
Not listed Hickory North Carolina 28601 —
Not listed Oklahoma City Oklahoma 73118 —
Not listed Franklin Tennessee 37064 —
Not listed Bedford Texas 76022 —
Not listed Waukesha Wisconsin 53188 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 48 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01862640, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 31, 2020 · Synced Oct 27, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01862640 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →